A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2

The rapid expansion of the COVID-19 pandemic has made the development of a SARS-CoV-2 vaccine a global health and economic priority. Taking advantage of versatility and rapid development, three SARS-CoV-2 mRNA vaccine candidates have entered clinical trials with a two-dose immunization regimen. Howe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nat Commun
Päätekijät: Huang, Qingrui, Ji, Kai, Tian, Siyu, Wang, Fengze, Huang, Baoying, Tong, Zhou, Tan, Shuguang, Hao, Junfeng, Wang, Qihui, Tan, Wenjie, Gao, George F., Yan, Jinghua
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7858593/
https://ncbi.nlm.nih.gov/pubmed/33536425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-021-21037-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia